Oric Pharmaceuticals Inc Long-term Investment Intensity

Latest as of June 2026: 30.3%

Oric Pharmaceuticals Inc long-term investment intensity. Oric Pharmaceuticals Inc (ORIC) has a Long-term Investment Intensity of 30.3% as of June 2026. Long-term investments of $122.80 Million represent 30.3% of total assets of $404.69 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read Oric Pharmaceuticals Inc debt and liabilities for a breakdown of total debt and financial obligations.

LT Investment Intensity

30.3%
LT Investments / Total Assets

Long-term Investments

$122.80 Million
USD

Total Assets

$404.69 Million
USD

Country

USA
NASDAQ

Long-term Investment Intensity of Oric Pharmaceuticals Inc (2021–2025)

Long-term investment intensity of Oric Pharmaceuticals Inc from 2021 to 2025. This chart shows how Oric Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 4 annual periods from 2021 to 2025. As of June 2026, the intensity stands at 30.3%, reflecting long-term investments of $122.80 Million against total assets of $404.69 Million USD.

Oric Pharmaceuticals Inc Long-term Investment Intensity by Year (2021–2025)

Oric Pharmaceuticals Inc long-term investment intensity by year from 2021 to 2025. The table below presents the year-by-year Long-term Investment Intensity for Oric Pharmaceuticals Inc from 2021 to 2025, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Oric Pharmaceuticals Inc asset portfolio.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2025 26.9% $110.76 Million $411.00 Million ▲ +16.4 pp
2023 10.5% $26.85 Million $254.69 Million ▲ +1.8 pp
2022 8.8% $21.95 Million $250.36 Million ▼ -5.8 pp
2021 14.5% $43.39 Million $298.64 Million —
pp = percentage points